Abstract
In the manuscript, the acknowledgements section currently reads “none”. The correct acknowledgement should be “this publication was based on research using data from data contributors Pfizer, AbbVie, and Takeda, that has been made available through Vivli, Inc. Vivli has not contributed to or approved, and is not in any way responsible for the contents of this publication.” The error occurred during the final stages of the manuscript preparation. When we were making final edits and formatting adjustments, the acknowledgements section was inadvertently overlooked The correction of this acknowledgement does not alter the main results or conclusions of the paper. We believe that these changes will more accurately reflect the contributions and support that were instrumental in the completion of our study. We regret our oversight in failing to include this information in the acknowledgements section of this paper.
Original language | English (US) |
---|---|
Article number | 102980 |
Journal | EClinicalMedicine |
Volume | 78 |
DOIs |
|
State | Published - Dec 2024 |
Funding
CM consulting fees from AbbVie, Alimentiv, Amgen, AVIR Pharma Inc, BioJAMP, Bristol Myers Squibb, Celltrion, Ferring, Fresenius Kabi, Janssen, McKesson, Mylan, Takeda, Pendopharm, Pfizer, Roche; speaker's fees from AbbVie, Amgen, AVIR Pharma Inc, Alimentiv, Bristol Myers Squibb, Ferring, Fresenius Kabi, Janssen, Takeda, Pendopharm, and Pfizer; royalties from Springer Publishing; research support from Ferring, Pfizer.
ASJC Scopus subject areas
- General Medicine